QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 A novel mouse model of orthotopic extrahepatic cholangiocarcinoma confirmed with molecular imaging 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2019, 卷号: 8, 期号: 2, 页码: 583-591 作者:  Song, Xiaodong;  Shao, Zili;  Han, Menglin;  Liang, Huihong 收藏  |  浏览/下载：57/0  |  提交时间：2019/07/12 Extrahepatic cholangiocarcinoma (extrahepatic CCA)  xenograft  orthotopic  mice model  molecular imaging   Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature 期刊论文 DIGESTIVE AND LIVER DISEASE, 2018, 卷号: 50, 期号: 4 作者:  Dong, Yi;  Teufel, Andreas;  Trojan, Joerg;  Berzigotti, Annalisa;  Cui, Xin Wu 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Contrast-enhanced ultrasound (CEUS)  Diagnosis  Differentiate  Mixed hepatocellular cholangiocarcinoma (HCC-CCA)   Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth 期刊论文 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 卷号: 504, 期号: 4, 页码: 654-659 作者:  Li, Yong;  Cai, Quanyu;  Li, Wanhu;  Feng, Feiling;  Yang, Liang 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 LncRNA  Lnc-EPIC1  Cholangiocarcinoma (CCA)  MYC   Roles of microRNA in liver cancer 期刊论文 Liver Research, 2018, 卷号: 2, 期号: 2, 页码: 61-72 作者:  Tao J.;  Jiang L.;  Chen X. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 Cholangiocarcinoma (CCA)  Diagnosis  Hepatoblastoma (HB)  Hepatocellular carcinoma (HCC)  Liver cancer  MicroRNAs (miRNAs)  Therapy   A Mouse Model of Cholestasis-Associated Cholangiocarcinoma and Transcription Factors Involved in Progression 期刊论文 Gastroenterology, 2011, 卷号: 141, 期号: 1, 页码: 378-388.e4 作者:  Yang, Heping*;  Li, Tony W. H. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03 Liver Disease  Transcriptional Regulation  Cell Cycle  Carcinogenesis  ALT  alanine aminotransferase  CA  cholangiomas  CBDL  common bile duct ligation  CCA  cholangiocarcinoma  ChIP  chromatin immunoprecipitation  DEN  diethylnitrosamine  DD  DEN IP+DEN oral gavage  DL  DEN IP+LMBDL  DLD  DEN IP+LMBDL+DEN oral gavage  HCC  hepatocellular carcinoma  HIF  hypoxia-inducible factor  IP  intraperitoneal  LHBDL  left hepatic bile duct ligation  LMBDL  left and median bile duct ligation  miR  microRNA  shRNA  short hairpin RNA  siRNA  small inhibitor RNA  PCNA  proliferating cell nuclear antigen